Focus on acute leukemias

被引：137

作者：

Gilliland, DG

Tallman, MS

机构：

[1] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Harvard Inst Med, Dana Farber Canc Inst, Boston, MA 02115 USA

[3] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA

来源：

CANCER CELL | 2002年 / 1卷 / 05期

关键词：

D O I：

10.1016/S1535-6108(02)00081-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：417 / 420

页数：4

共 33 条

[21] A 5-DRUG REMISSION INDUCTION REGIMEN WITH INTENSIVE CONSOLIDATION FOR ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CANCER AND LEUKEMIA GROUP-B STUDY-8811 [J].

LARSON, RA ;

DODGE, RK ;

BURNS, CP ;

LEE, EJ ;

STONE, RM ;

SCHULMAN, P ;

DUGGAN, D ;

DAVEY, FR ;

SOBOL, RE ;

FRANKEL, SR ;

HOOBERMAN, AL ;

WESTBROOK, CA ;

ARTHUR, DC ;

GEORGE, SL ;

BLOOMFIELD, CD ;

SCHIFFER, CA .

BLOOD, 1995, 85 (08) :2025-2037

[22] INTENSIVE POSTREMISSION CHEMOTHERAPY IN ADULTS WITH ACUTE MYELOID-LEUKEMIA [J].

MAYER, RJ ;

DAVIS, RB ;

SCHIFFER, CA ;

BERG, DT ;

POWELL, BL ;

SCHULMAN, P ;

OMURA, GA ;

MOORE, JO ;

MCINTYRE, OR ;

FREI, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) :896-903

[23]

Mrózek K, 2000, INT J HEMATOL, V72, P261

[24] Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors [J].

Okuda, T ;

Cai, ZL ;

Yang, SL ;

Lenny, N ;

Lyu, CJ ;

van Deursen, JMA ;

Harada, H ;

Downing, JR .

BLOOD, 1998, 91 (09) :3134-3143

[25]

Sanz MA, 2000, BLOOD, V96, P1247

[26]

SCHEINBERG DA, 2001, CANC PRINCIPLES PRAC

[27] Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse [J].

Sievers, EL ;

Larson, RA ;

Stadtmauer, EA ;

Estey, E ;

Löwenberg, B ;

Dombret, H ;

Karanes, C ;

Theobald, M ;

Bennett, JM ;

Sherman, ML ;

Berger, MS ;

Eten, CB ;

Loken, MR ;

van Dongen, JJM ;

Bernstein, ID ;

Appelbaum, FR .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3244-3254

[28] Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study [J].

Slovak, ML ;

Kopecky, KJ ;

Cassileth, PA ;

Harrington, DH ;

Theil, KS ;

Mohamed, A ;

Paietta, E ;

Willman, CL ;

Head, DR ;

Rowe, JM ;

Forman, SJ ;

Appelbaum, FR .

BLOOD, 2000, 96 (13) :4075-4083

[29] United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia [J].

Soignet, SL ;

Frankel, SR ;

Douer, D ;

Tallman, MS ;

Kantarjian, H ;

Calleja, E ;

Stone, RM ;

Kalaycio, M ;

Scheinberg, DA ;

Steinherz, P ;

Sievers, EL ;

Coutré, S ;

Dahlberg, S ;

Ellison, R ;

Warrell, RP .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) :3852-3860

[30] All-trans-retinoic acid in acute promyelocytic leukemia [J].

Tallman, MS ;

Andersen, JW ;

Schiffer, CA ;

Appelbaum, FR ;

Feusner, JH ;

Ogden, A ;

Shepherd, L ;

Willman, C ;

Bloomfield, CD ;

Rowe, JM ;

Wiernik, PH .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) :1021-1028

← 1 2 3 4 →